Literature DB >> 16913971

Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host.

L J Wheat1.   

Abstract

Understanding the uses and limitations of methods for rapid diagnosis of fungal disease is essential in order to diagnose and treat these infections early in their course. Antigen detection methods are useful for diagnosis of aspergillosis, cryptococcosis, histoplasmosis, blastomycosis, paracoccidioidomycosis, and penicilliosis marneffei. The accuracy of the beta-glucan assay for diagnosis of aspergillosis and candidiasis and its role in fungal diagnosis remains unclear, in part because the few published studies report widely varying specificity. Serologic tests for antibodies are also useful for diagnosis of histoplasmosis and coccidioidomycosis, but their sensitivity may be reduced by immunosuppression. While molecular diagnostic methods have been described and are available at some reference and university laboratories, their role in patient care remains uncertain, largely because of the lack of well-characterized assays and studies establishing their accuracy. Culture methods, although essential for establishing the diagnosis in some cases, have limitations for rapid diagnosis, namely insensitivity, need for invasive procedures, and delayed growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16913971     DOI: 10.1111/j.1399-3062.2006.00165.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  20 in total

1.  Platelia Aspergillus assay for diagnosis of disseminated histoplasmosis.

Authors:  S Ranque; R Pelletier; A Michel-Nguyen; F Dromer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

2.  Clinical significance of low-positive histoplasma urine antigen results.

Authors:  Elitza S Theel; Poornima Ramanan
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

3.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

4.  Answer to January 2020 Photo Quiz.

Authors:  Sarah Jung; Nancy Wengenack; Min Shi; Audrey N Schuetz
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

5.  Nonculture diagnostic methods for invasive fungal infections.

Authors:  L Joseph Wheat
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

6.  High-throughput identification and quantification of Candida species using high resolution derivative melt analysis of panfungal amplicons.

Authors:  Tasneem Mandviwala; Rupali Shinde; Apoorv Kalra; Jack D Sobel; Robert A Akins
Journal:  J Mol Diagn       Date:  2009-12-10       Impact factor: 5.568

Review 7.  Endemic Mycoses in Solid Organ Transplant Recipients.

Authors:  Jeremy S Nel; Luther A Bartelt; David van Duin; Anne M Lachiewicz
Journal:  Infect Dis Clin North Am       Date:  2018-09       Impact factor: 5.982

8.  Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America.

Authors:  Cesar Muñoz; Beatriz L Gómez; Angela Tobón; Karen Arango; Angela Restrepo; Margarita M Correa; Carlos Muskus; Luz Elena Cano; Angel González
Journal:  Clin Vaccine Immunol       Date:  2009-11-25

9.  Evaluation of an enzyme immunoassay for detection of Histoplasma capsulatum antigen from urine specimens.

Authors:  Elitza S Theel; Deborah J Jespersen; Julie Harring; Jay Mandrekar; Matthew J Binnicker
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

Review 10.  Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy.

Authors:  Jeannina A Smith; Carol A Kauffman
Journal:  Drugs       Date:  2009-07-30       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.